5-MeO-DMT alters cortical activity in primary sensory areas (Au1, S1, V1) and PFC.
5-MeO-DMT disrupts oscillatory activity in visual cortex through 5-HT1A receptors.
5-MeO-DMT disrupt oscillatory activity in PFC via 5-HT1A and 5-HT2A receptors.
Antipsychotic drugs restore oscillatory activity after 5-MeO-DMT treatment.
5-MeO-DMT reduces 5-HT release in PFC mainly through 5-HT1A receptors.